أعرض في EDS

Improving beta-cell secretory function and glycaemia in young-onset type 2 diabetes: A pilot, 12-month, randomized trial of a novel, continuous glucose monitor-guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide

التفاصيل البيبلوغرافية
العنوان:	Improving beta-cell secretory function and glycaemia in young-onset type 2 diabetes: A pilot, 12-month, randomized trial of a novel, continuous glucose monitor-guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide
المؤلفون:	Timothy L. Middleton, Maria I. Constantino, Margaret McGill, Mario D’Souza, Dennis K. Yue, Stephen M. Twigg, Ted Wu, Jencia Wong
المصدر:	Diabetes, obesitymetabolismREFERENCES. 24(4)
سنة النشر:	2021
مصطلحات موضوعية:	Blood Glucose, Endocrinology, Diabetes Mellitus, Type 2, Glucosides, Endocrinology, Diabetes and Metabolism, Internal Medicine, Humans, Hypoglycemic Agents, Benzhydryl Compounds, Liraglutide
تدمد:	1463-1326
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d9746f568f0b3422ff626d29b73dcc4 https://pubmed.ncbi.nlm.nih.gov/34882926
حقوق:	CLOSED
رقم الأكسشن:	edsair.doi.dedup.....6d9746f568f0b3422ff626d29b73dcc4
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	14631326